Xcout IntelSign inSubscribe

INTEGRAGEN competitors & alternatives

ALINTBiotechFrance

The 12 closest competitors and alternatives to INTEGRAGEN among biotech companies — ranked by similarity to what INTEGRAGEN actually does, not by market-cap band.

12Competitors listed

Subscribe to see INTEGRAGEN’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About INTEGRAGEN

IntegraGen develops genomic tests, molecular diagnostic products, and bioinformatics software for researchers, clinicians, and biopharma companies. The company specializes in oncology and genetic diseases, offering next-generation sequencing services, data analysis tools, and biomarker identification to support clinical research and diagnostics.

Top 12 INTEGRAGEN competitors

Ranked by semantic similarity — how close each company is to INTEGRAGEN by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

INTERPACE BIOSCIENCES, INC.IDXG · BiotechParsippany, United States
72% matchPublic

Similar biotech company

Interpace Biosciences, Inc. is a U.S.-based company specializing in advanced molecular diagnostic tests, bioinformatics, and pathology services, primarily focused on assessing cancer risk. Among its key offerings is PancraGEN, a comprehensive genomic test for pancreatic cysts and solid lesions within the pancreaticobiliary system. This test, powered by the proprietary PathFinderTG platform, assists medical professionals in more accurately determining the risk of pancreaticobiliary cancers. It also offers PanDNA, a molecular-only variant of PancraGEN, which delivers insights into a select number of diagnostic markers. For thyroid health, the company provides ThyGeNEXT, an oncogenic mutation panel designed to identify malignant thyroid nodules. Additionally, ThyraMIR evaluates thyroid nodules for malignancy risk through the application of its proprietary microRNA gene-expression assay. Furthermore, RespriDx is a genomic diagnostic tool that aids clinicians in distinguishing between metastatic and recurrent lung cancer. Interpace Biosciences further supports the pharmaceutical and biotechnology sectors with services including pharmacogenomics testing, genotyping, biorepository solutions, and various custom scientific offerings. Its clientele primarily consists of physicians, hospitals, and clinics. Previously operating as Interpace Diagnostics Group, Inc., the company adopted its current name, Interpace Biosciences, Inc., in November 2019. Founded in 1986, its corporate headquarters are located in Parsippany, New Jersey.

Market cap$35.4M
Employees111
INTERPACE BIOSCIENCES, INC. competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of INTEGRAGEN and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for INTEGRAGENand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →